Anders Sveno

Anders Sveno is a seasoned professional in the field of regulatory affairs, currently serving as CMC Regulatory Affairs Director at AstraZeneca since 2025. Previously, Anders held leadership roles such as Head of RA CMC and Post Market Development at Karo Healthcare and Head of CMC at Egetis Therapeutics AB. With extensive experience at Meda and AstraZeneca R&D, where they developed regulatory strategies and managed process chemistry teams, Anders has a strong foundation in drug development and regulatory compliance. Anders earned a degree in Organic Chemistry from Mid Sweden University and completed a single course in Analytical Chemistry at Stockholm University.